Wallace Kris, Fleshner Neil, Jewett Michael, Basiuk Joan, Crook Juanita
Department of Radiation Medicine and the Division of Urology, Princess Margaret Hospital, University Health Network, Toronto, Canada.
J Clin Oncol. 2006 Sep 1;24(25):4158-62. doi: 10.1200/JCO.2006.06.3875.
Random assignment to clinical trials involving different treatment modalities can be difficult. We describe our experience with the Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial (SPIRIT; ACOSOG Z0070 NCIC PR10), a randomized trial for early-stage prostate cancer comparing radical prostatectomy (RP), and brachytherapy (BT). A multidisciplinary educational session was developed to improve patient understanding of treatment options and to facilitate accrual.
Prostate cancer referrals were screened and men who met favorable risk criteria (T1c/T2a, prostate-specific antigen [PSA] < 10 ng/mL, Gleason < or = 6) were invited to a structured education session before a specialty consultation. Men and their partners viewed the SPIRIT informed-consent video and heard from a cancer patient who described his participation in a randomized trial. Then, a urologist and radiation oncologist together compared and contrasted RP and BT to establish the rationale for the trial.
In May 2002, SPIRIT opened for accrual and was endorsed by the University Health Network urologists and radiation oncologists. The first 27 eligible patients were approached about SPIRIT, consulted both specialties, and viewed an educational video. No patients consented. The multidisciplinary education session was then introduced. Forty-seven education sessions with 263 patients resulted in 34 consents. Of 203 patients who were suitable for the study but declined random assignment, 62 chose surgery, 94 chose brachytherapy, three patients chose external radiotherapy, and 11 chose no treatment. Consent rates for eligible and suitable patients were one in six.
Men who understand their treatment options and trial rationale as presented jointly by representative specialists from competing treatment modalities may be better equipped to make an informed decision and are more likely to consent to random assignment.
随机分配患者参与涉及不同治疗方式的临床试验可能具有挑战性。我们描述了我们在前列腺癌根治术与间质放疗干预试验(SPIRIT;美国外科医师学会肿瘤学组Z0070,加拿大国家癌症研究所PR10)中的经验,这是一项针对早期前列腺癌的随机试验,比较了根治性前列腺切除术(RP)和近距离放射治疗(BT)。开展了一次多学科教育会议,以提高患者对治疗选择的理解并促进入组。
对前列腺癌转诊患者进行筛选,符合有利风险标准(T1c/T2a,前列腺特异性抗原[PSA]<10 ng/mL,Gleason评分≤6)的男性在专科会诊前被邀请参加一次结构化教育会议。男性患者及其伴侣观看了SPIRIT知情同意视频,并听取了一位描述其参与随机试验经历的癌症患者的讲述。然后,一名泌尿科医生和一名放射肿瘤学家共同比较并对比了RP和BT,以确立该试验的基本原理。
2002年5月,SPIRIT开始入组,并得到了大学健康网络的泌尿科医生和放射肿瘤学家的认可。最初向27名符合条件的患者介绍了SPIRIT,他们咨询了两个专科并观看了教育视频。但没有患者同意参与。随后引入了多学科教育会议。47次教育会议共涉及263名患者,其中34人同意参与。在203名适合该研究但拒绝随机分配的患者中,62人选择了手术,94人选择了近距离放射治疗,3人选择了外照射放疗,11人选择了不治疗。符合条件且适合的患者的同意率为六分之一。
那些理解了由来自相互竞争的治疗方式的代表性专家共同介绍的治疗选择和试验基本原理的男性,可能更有能力做出明智的决定,并且更有可能同意随机分配。